Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy

NCT07265414 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.

NCT NCT07265414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07265414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
Lead sponsor
Istituto Clinico Humanitas
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2021
Completion date
January 31, 2026
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, prostate cancer